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MaAtherosclerotic cardiovascular disease (ASCVD) continues to increase annually in the United States along with its asso-
ciated enormous costs. A multidisciplinary cardiac rehabilitation (CR) and risk reduction program is an essential
component of ASCVD prevention and management. Despite the strong evidence for CR in the secondary prevention of
ASCVD, it remains vastly underutilized due to signiﬁcant barriers. The current model of CR delivery is unsustainable and
needs signiﬁcant improvement to provide cost-effective, patient-centered, comprehensive secondary ASCVD
prevention. (J Am Coll Cardiol 2015;65:389–95) © 2015 by the American College of Cardiology Foundation.T he growing epidemics of obesity (almost 35%of adults with a body mass index $30 kg/m2),metabolic syndrome (35% of adults), dia-
betes mellitus (8.3% of adults had diagnoses of
diabetes, and 38.2% were pre-diabetic), sedentary
lifestyle (around 30% of the population reported
physical inactivity in 2012, and 49.9% did not meet
the federal aerobic physical activity guidelines for
adults), hypertension (33% of adults), and smoking
(20.5% of men and 15.9 % women) contribute to the
increasing burden and prevalence of atherosclerotic
cardiovascular disease (ASCVD) in the United States
(1,2). An estimated 75% to 90% incidence of coronary
artery disease (CAD) in a variety of populations is
explained by antecedent exposure to conventional
risk factors, inﬂuenced by the most proximal
or foundational factors for heart disease, including
poor dietary habits, physical inactivity, and ciga-
rette smoking (Central Illustration) (3–5). With ASCVD
increasing annually and costs related to ASCVD and
stroke exceeding $315 billion in 2010, and projected
to triple over the next 20 years, there is a clear needm the *Division of Cardiology, Department of Medicine, Emory Univers
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Since 1995, CR has been deﬁned as “the provision of
comprehensive long-term services involving medical
evaluation, prescriptive exercise, cardiac risk factor
modiﬁcation, and education, counseling, and behav-
ioral interventions” (7).
Exercise can be viewed as a preventive medical
treatment, like a “pill” that should be taken on
an almost daily basis.
—2013 American Heart Association scientiﬁc statement
on exercise standards for testing and training (8)
Beneﬁcial cardioprotective effects of physical ac-
tivity and cardiorespiratory ﬁtness include improve-
ments in multiple ASCVD risk factors together with
antiatherogenic, anti-inﬂammatory, anti-ischemic,
antithrombotic, and antiarrhythmic effects (Table 1)
(8,9). The efﬁcacy of exercise-based CR in secondary
prevention of ASCVD is well established. A systematic
review andmeta-analysis of 34 randomized controlled
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390associated with a lower risk of reinfarction
(odds ratio [OR]: 0.53; 95% conﬁdence interval
[CI]: 0.38 to 0.76), cardiac mortality (OR: 0.64;
95% CI: 0.46 to 0.88), and all-cause mortality
(OR 0.74, 95% CI: 0.58 to 0.95) (22). Another
meta-analysis of randomized controlled trials
showed that compared with usual care, pa-
tients in the exercise-based CR group had
greater improvements in ASCVD risk factors
such as lipid levels and systolic blood pressure
and had lower rates of self-reported smoking(23). Notably, the effect of CR on total mortality wasRAL ILLUSTRATION Cardiac Rehabilitation and the
Subclinical Disease
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id (left) shows how unhealthy lifestyle practices lead to developm
es or clinical endpoints. There are 3 types of prevention: primordi
ary (prevention of recurrent cardiovascular events), which can be
rs, lifestyle changes, and cardioprotective medications, if approp
is to favorably modify unhealthy lifestyle habits or practices, i
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I (inpatient phase) involves physical therapy and patient educa
ualized exercise prescription and risk factor reduction under su
ependent continuation of the exercise program and cardiovascu
ferring physician with ongoing valuable surveillance data (such
oms) that can aid with ongoing medical management of the pa
tion; ASCVD ¼ atherosclerotic cardiovascular disease; CABG ¼
yocardial infarction; NSTEMI ¼ non-ST-segment elevation my
percutaneous coronary intervention.independent of whether the trial was published before
or after 1995, suggesting that the mortality beneﬁts
of CR persist in modern cardiology. Patients who un-
dergo percutaneous coronary intervention or coronary
artery bypass graft surgery also beneﬁt from CR, with
a reduction in all-cause mortality of 20% to 50%
compared with that in the control groups receiving
usual care (24–26). Additional documented beneﬁts
of CR include improved exercise performance and
health-related quality of life (QOL), decreased hos-
pitalizations, and reduced depression and anginal
symptoms (23,27,28).ASCVD Prevention Pyramid
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al (prevention of risk factors); primary (treatment of risk factors); and
modulated by environmental (e.g., air pollution) and psychosocial
riate. The ﬁrst-line strategy to prevent initial or recurrent cardiac
ncluding poor dietary habits, physical inactivity, and cigarette
ry prevention programs. The current model of CR involves 3 phases.
tion after a cardiac event. Phase II (outpatient phase) consists of
pervision of a medical team. Phase III (maintenance phase) consists
lar risk reduction learned during phase II (37,39). CR also provides
as exertional angina symptoms, onset of AF, heart failure
tient. Adapted with permission from Franklin et al. (5). AF ¼ atrial
coronary artery bypass graft; CHF ¼ congestive heart failure;
ocardial infarction; PAD ¼ peripheral arterial disease;
TABLE 1 Potential Cardioprotective Effects of Increased Lifestyle Activity,
Structured Exercise, and/or Improved Cardiorespiratory Fitness
Anti-inﬂammatory Reduced plasma level of C-reactive protein, which is a
biomarker of inﬂammation (10)
Antithrombotic Decreased platelet aggregation (11)
Enhanced ﬁbrinolysis activity (12)
Antiarrhythmic Improved cardiac autonomic function (13,14)
Increased vagal tone and decreased sympathetic activity (14)
Antiatherogenic Improvement in established ASCVD risk factors
Improved endothelial function due to increased blood ﬂow and
shear stress on arterial walls (15,16)
Enhanced synthesis and release of nitric oxide, which is responsible
for the inhibition of processes involved in atherogenesis (15)
Improved ASCVD
risk factors
Decrease in total cholesterol, LDL-C, and triglycerides (17)
Increase in HDL-C levels (17)
Reduced blood pressure (18)
Increased insulin sensitivity (19)
Weight reduction (19)
Anti-ischemic Improved myocardial perfusion (20)
Raised ischemic threshold (11)
Ischemic preconditioning of the myocardium (21)
ASCVD ¼ atherosclerotic cardiovascular disease; HDL-C ¼ high-density lipoprotein cholesterol; LDL-C ¼
low-density lipoprotein cholesterol.
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391In the HF-ACTION (Heart Failure: A Controlled
Trial Investigating Outcomes of Exercise Training)
study, patients with systolic heart failure randomized
to an exercise training program had hazard ratios of
0.89 (p ¼ 0.03), 0.91 (p ¼ 0.09), and 0.85 (p ¼ 0.03) for
all-cause mortality or hospitalization, cardiovascular
mortality or cardiovascular hospitalization, and car-
diovascular mortality or heart failure hospitalization,
respectively (29). Patients in the exercise training
program also demonstrated signiﬁcant improvements
in QOL measures after 3 months that were sustained
at 3 years’ follow-up (30). Similarly, a recent Cochrane
review of 33 trials in patients with heart failure
with reduced or preserved ejection fraction found
a decreased risk of hospital admissions and im-
provement in health-related QOL for patients in the
exercise-based rehabilitation group compared with
that in the control group receiving usual care (31).
Hence, CR programs confer signiﬁcant beneﬁts on
patients with heart failure through reduced mortality,
enhanced QOL, and reduced hospitalizations.
HISTORICAL PERSPECTIVE
In the 1930s, restriction of physical activity and
prolonged bed rest were standard of care for
patients with myocardial infarction (MI) (32). Sub-
sequent evolution of practices such as chair therapy
(1940s), brief daily walks of 3 to 5 min (1950s), and
structured inpatient CR programs for early ambulation
post-MI (1960s) led to the development of contempo-
rary multidisciplinary, comprehensive CR and sec-
ondary prevention programs for patients with ASCVD
(32–37).
CURRENT MODEL OF CR
IN THE UNITED STATES
In the current U.S. healthcare system, CR continues to
evolve as a treatment modality (Central Illustration).
Until recently, CR was approved for insurance
coverage by Medicare only for patients with chronic
stable angina pectoris and/or who had sustained an MI
(NSTEMI or STEMI) in the last 12 months, or had un-
dergone cardiac surgery (coronary artery bypass, valve
replacement/repair, or heart/heart-lung transplant) or
percutaneous coronary intervention. After approxi-
mately 20 years of deliberation, Medicare recently
approved systolic heart failure as a reimbursable
diagnosis for CR (38). To improve timely referrals and
enrollment in this vastly underutilized treatment op-
tion, the American Association of Cardiovascular and
Pulmonary Rehabilitation, the American College of
Cardiology (ACC), and the American Heart Association
(AHA) have published performance measurements forthe referral and delivery of CR services designed for
hospital settings, ofﬁce practices, and university set-
tings (39–41). Although there are class IA recommen-
dations for CR in the AHA/ACC management
guidelines and performance measures, up to 80% of
eligible patients are apparently not referred (42).
Speciﬁc patient populations including the elderly,
women, ethnic minorities, and people of lower socioeco-
nomic status have especially low referral rates (9). There
are at least 4 reasonswhy eligible patients are not referred
for CR, namely: 1) lack of a centralizedmethod for referral;
2) inadequate communication among treatment teams,
patients, and CR facilities; 3) unfamiliarity with CR among
potential referring physicians; and, 4) limited access,
competing responsibilities, and perceived inconvenience
for the patient (9,39,42–44).
Even among patients who are appropriately and/or
automatically referred to CR, certain patients are less
likely to enroll and, once enrolled, are more likely to
drop out. Within 1 and 6 months after acute MI, only
29% and 48% of referred patients participated in CR,
respectively (43). Predictors of suboptimal participa-
tion include poor functional status, higher body mass
index, tobacco use, depression, long-distance to CR
facilities, low health literacy, high costs (e.g., copays),
and inﬂexible work schedules (42). Relevant data
from European CR programs indicate that, once
referred, patients are more likely to enroll and com-
plete CR due to stronger ﬁnancial assistance (national
health insurance pays) and employer support for
employee health needs (45).
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392FUTURE OF CR
The current model of CR delivery appears to be
neither ﬁnancially viable nor sustainable due to
barriers to consistent and appropriate referral (espe-
cially for women, the elderly, ethnic minorities, and
low socioeconomic status populations), accessibility
(transportation, number, and geographic distribution
of CR programs), and affordability (lack of insurance
coverage, high copayments, and use of resource-
intensive, inefﬁcient and costly models) (46). Ac-
cording to a recent AHA science advisory, many CR
programs do not receive adequate referrals to main-
tain ﬁnancial viability (44). In another recent
report, none of the 3 CR programs included in the
analysis generated revenues that were sufﬁcient to
cover costs (47).s of Conventional Cardiac Rehabilitation and Secondary Prevention
ure Trends
19 individuals with self-reported atherosclerotic cardiovascular disease,
moke cigarettes, just 35% undertook recommended levels of moderate-
l activity, and only 39% had healthy diets (60). Moreover, a substantial
nts receiving percutaneous coronary intervention do not achieve lifestyle
s at 1 year after procedure and therefore remain at increased risk for
ents or coronary revascularization procedures (61). Early referral and
p should help to improve program access and compliance with lifestyle
habilitation (CR) programs routinely emphasize structured exercise and
lectrocardiographic monitoring for reimbursement, yet the primary
ctured exercise programs are those at the bottom of the ﬁtness/activity
e least ﬁt, least active cohort (i.e., the bottom 20%) (62). Contemporary
d prioritize low-ﬁt patients and increasingly focus on facilitating long-
ge (e.g., promoting lifestyle physical activity) and comprehensive risk
orating new modalities such as home-based, internet-based, and
programs.
of patients are discharged with appropriate medications after acute
n, most patients receive doses prescribed substantially below those with
linical trials (63). For a variety of reasons (e.g., cost, adverse effects,
nts also report inconsistent long-term use of beta-blockers, lipid-
r combinations of these potentially lifesaving drugs (64). In multivariate
nonadherence remained signiﬁcantly associated with increased all-cause
ients with coronary artery disease (65). A potential solution that will
mes of patients with coronary disease is to target medication dosing and
uality improvement initiatives in CR.
chronic disease typically spend $5,000 h each year independent of
it is critical to arm them with research-based behavior change strategies
ment in their immediate environment (e.g., home, work, community)
sages about lifestyle counseling to patients’ individual readiness to
e the likelihood of behavioral transformation (67), as will motivational
rm of talk therapy during patient encounters (68,69).
lts currently have an established source of healthcare services, and this
ted to appreciably increase with implementation of the Affordable Care
nable vulnerable subsets of the population, who are more often plagued
le practices, to seek medical evaluation and care, empowering medical
htened opportunities to facilitate behavioral improvements in population
0). The 5As approach can be used to elicit signiﬁcant improvements in a
haviors, including smoking cessation, dietary choices, and physical
, meeting certain health metrics) will become a greater priority in the new
e environment. For example, completing health habit surveys and/or
ﬁles, along with regular physical examinations, and attaining certain risk
e increasingly mandated by insurers and employers, orchestrated in part
es and penalties.
.As highlighted in the AHA science advisory
referred to earlier, further efforts must be made going
forward to systematically increase CR program par-
ticipation. In addition to escalating research initia-
tives to ﬁll knowledge gaps in the CR literature, these
efforts include: 1) educating providers, healthcare
systems, patients, and their families about the bene-
ﬁts of CR (including efforts to change the perception
that CR is less important than pharmacological or
interventional/surgical therapy); 2) reducing spe-
ciﬁc barriers to referral and participation in CR
that are attributable to patients (e.g., lack of knowl-
edge of beneﬁts and motivation to participate), phy-
sicians/health systems (e.g., perception of value of CR
and acute care priority), and the community (e.g.,
availability of programs and public policy); 3) pro-
moting a better understanding of CR as a cost-
effective, multidisciplinary, secondary prevention
treatment option and chronic disease management
service, rather than an exercise-only, gym-based
therapy; 4) continuing efforts to increase insurance
coverage and decrease copays for CR services;
5) increasing awareness of CR performance measures
and use of system-based approaches such as auto-
matic referral and discharge checklists for eligible
patients; 6) expanding the spectrum of respon-
sibilities of home health nurses, clinical exercise
physiologists, physical therapists, and other health-
care providers to provide home-based or community-
based CR; and 7) continuing innovative strategies
to bring CR to more patients (44).
Regarding the use of innovative strategies to bring
exercise-based CR to more patients, new delivery
models must be adopted, especially for patients at
low or low-to-intermediate risk. These include the
use of telemedicine as well as internet-based, home-
based, and community-based programs to provide
alternatives to conventional, medically supervised,
facility-based programs (48,49). Home-based pro-
grams using appropriately qualiﬁed nonphysician
health professionals to supervise and monitor patient
care is practical and feasible and has shown outcomes
in patients with CAD similar to those for conventional
hospital-based programs (49–52). From a medical-
legal liability perspective, appropriately prescribed
home-based exercise programs in selected patients
have been reported to be acceptably safe and effec-
tive, compared with conventional, medically super-
vised group programs (7,39,50).
Given Americans’ increasing access to mobile
phones and Internet, telemedicine programs are
emerging as promising alternatives to in-person pro-
grams, with improved accessibility and reduced costs
(53). Home-based CR interventions are equally if not
J A C C V O L . 6 5 , N O . 4 , 2 0 1 5 Sandesara et al.
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393more cost-effective than conventional center-based
programs (54–56).
As emphasized in a recent presidential advisory
from the AHA, these new CR delivery models should
not replace conventional programs but should be
used to help better meet the various needs of indi-
vidual patients, to engage the many patients who
currently do not participate, and to provide ongoing
monitoring and treatment after completion of a con-
ventional CR program (46). Moreover, experimental
or hybrid CR delivery models should not be widely
adopted until they have been shown to be both clin-
ically effective and cost effective (46).
The Affordable Care Act is a paradigm shift in the
United States and provides potential opportunities
for the deployment of new models of CR (57,58). In
addition to beneﬁting patients with ASCVD, new CR
delivery models may be especially well suited to
apparently healthy patients with risk factors or sub-
clinical disease, or both. Redesigning future ASCVD
interventions to attract and manage a wider spectrum
of patients, including primary prevention patients,
may help reduce personnel, program, and facility
redundancies.
CONCLUSIONS
An ounce of prevention is worth a pound of cure.
—Benjamin Franklin (73)
This enduring axiom remains as applicable today as
when it was ﬁrst promulgated. Fundamental objec-
tives of ASCVD prevention includemodiﬁcation of risk
factors such as obesity, metabolic syndrome, hyper-
tension, physical inactivity, unhealthy diet, smoking,
hyperlipidemia, diabetes, and psychosocial stressors
(particularly depression, which was recently elevated
to risk factor status by the AHA) (59), among others. CR
has evolved considerably since the 1930s and is
now viewed as a comprehensive multidisciplinary
approach to complex medical conditions requiring
behavioral, physical, emotional, and social caremanagement in the secondary prevention of ASCVD. It
has been almost 2 decades since the initial emphasis
on the urgent need to develop and implement “ap-
proaches that enable all persons with CAD to have
access to high-quality, cost-effective, long-term,
comprehensive ASCVD risk reduction and rehabilita-
tion services that are appropriate for their speciﬁc
needs and personal circumstances” (7). To achieve this
goal, we will need to adopt research-based behavioral
approaches and policies that increase patient motiva-
tion and self-responsibility, while overcoming the
deﬁciencies of conventional CR programs (Table 2)
(74). It has also been more than a decade since a ran-
domized clinical trial found that alternative ap-
proaches to conventional CR have the potential to
substantially reduce the costs of care while increasing
accessibility and achieving comparable improvements
in multiple risk factors in low-risk or moderate-risk
patients (75). Although our health care system has
made large strides, there is still room for signiﬁcant
improvement. How can the referral and participation
rates of eligible patients be increased? Should referral
be the responsibility of the physician or of the
healthcare team? How will working and nonworking
patients afford to pay for these services? The land-
scape of American healthcare delivery is dramatically
changing with passage of the Affordable Care Act. This
provides an opportune time to develop and implement
innovative ways to deliver comprehensive multidis-
ciplinary prevention interventions, including CR.
It is time to rebrand and reinvigorate. CR of the
future must be a patient-centered, comprehensive
secondary prevention program delivered through a
variety of easily accessible care models that empha-
size the value of CR in healthcare outcomes and cost
effectiveness.
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